Gut microbiota-dependent mechanisms and efficacy of natural polysaccharides in multitarget antidepressant therapy: a systematic review
Frontiers in Psychiatry · 29.06.2026 · 17
DOI: 10.3389/fpsyt.2026.1789107 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Psychiatry, online erschienen am 29.06.2026. Verfasst von Haoqi Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Beijing University of Chinese Medicine, Beijing, China. Die Arbeit nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Background
Depression is a mental disorder with emotional, physiological, and behavioral symptoms. Natural polysaccharides have attracted attention for their low toxicity and potential to improve depression, possibly through modulation of gut microbiota and related metabolic pathways. This systematic review aimed to summarize preclinical evidence on the antidepressant efficacy of natural polysaccharides and explore putative mechanisms involving the microbiota-gut-brain axis.
Methods
Following Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines, a comprehensive literature search was performed in PubMed, Web of Science, and Embase for studies up to October 4, 2025.
Results
Twenty preclinical studies met the inclusion criteria. Polysaccharide treatment was generally associated with improved depression-like behaviors, normalized neurotransmitter levels, and reduced inflammation and oxidative stress. These effects were accompanied by changes in intestinal barrier function, gut microbiota composition, and short-chain fatty acid metabolism. However, substantial heterogeneity and a high risk of bias across the included studies limit causal interpretation.
Conclusion
Natural polysaccharides show potential antidepressant effects in preclinical models, but the current evidence is preliminary. Well-designed translational and clinical studies are needed to advance these findings. Systematic review registration https://www.crd.york.ac.uk/PROSPERO/view/CRD420261284093 , identifier PROSPERO, CRD420261284093.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Beijing University of Chinese Medicine, Beijing, China.
- The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.
- The Second Clinical Medical College of Beijing University of Chinese Medicine, Beijing, China.
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Liu, H., Wang, M., Bai, C., Li, J., Dong, K., & Guo, R. (2026). Gut microbiota-dependent mechanisms and efficacy of natural polysaccharides in multitarget antidepressant therapy: a systematic review. Frontiers in Psychiatry, 17. https://doi.org/10.3389/fpsyt.2026.1789107
Vancouver
Liu H, Wang M, Bai C, Li J, Dong K, Guo R. Gut microbiota-dependent mechanisms and efficacy of natural polysaccharides in multitarget antidepressant therapy: a systematic review. Frontiers in Psychiatry. 2026;17. doi:10.3389/fpsyt.2026.1789107
BibTeX
@article{Liu2026,
author = {Liu, Haoqi and Wang, Min and Bai, Chen and Li, Jingchun and Dong, Kaiqiang and Guo, Rongjuan},
title = {Gut microbiota-dependent mechanisms and efficacy of natural polysaccharides in multitarget antidepressant therapy: a systematic review},
journal = {Frontiers in Psychiatry},
year = {2026},
volume = {17},
doi = {10.3389/fpsyt.2026.1789107}
}
EUVIMED